Aspire Biopharma Holdings, Inc. (ASBP) vs GT Biopharma, Inc. (GTBP)
Aspire Biopharma Holdings, Inc. and GT Biopharma, Inc. are both Biotechnology companies. Aspire Biopharma Holdings, Inc. and GT Biopharma, Inc. are of similar size ($12.3M and $12.2M). GT Biopharma, Inc. has negative trailing earnings, so its P/E is not meaningful; Aspire Biopharma Holdings, Inc. trades at 0.2×. GT Biopharma, Inc. has the higher net margin (0.00% vs −11,309.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Aspire Biopharma Holdings, Inc. leads on 8 and GT Biopharma, Inc. on 6.
Valuation
Profitability
| Metric | ASBP | GTBP | Biotechnology median |
|---|---|---|---|
| Gross margin | (24.97%) | 41.67% | 65.16% |
| Operating margin | (7,491.61%) | 0.00% | 0.00% |
| Net margin | (11,309.31%) | 0.00% | 0.00% |
| Free cash flow margin | (7,355.07%) | 0.00% | 0.00% |
| Return on equity | (1,032.15%) | 102.03% | (57.72%) |
| Return on assets | (152.09%) | (176.27%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack